首页> 外文期刊>Cancer biology & therapy >PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress.
【24h】

PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress.

机译:PDRG1,一种针对多种恶性肿瘤的新型肿瘤标志物,受遗传毒性应激选择性调节。

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously cloned and characterized a novel p53 and DNA damage-regulated gene named PDRG1. PDRG1 was found to be differentially regulated by ultraviolet (UV) radiation and p53. In this study, we further investigated stress regulation of PDRG1 and found it to be selectively regulated by agents that induce genotoxic stress (DNA damage). Using cancer profiling arrays, we also investigated PDRG1 expression in matching normal and tumor samples representing various malignancies and found its expression to be upregulated in multiple malignancies including cancers of the colon, rectum, ovary, lung, stomach, breast and uterus when compared to their respective matched normal tissues. Western blot and immunohistochemical analyses were also performed on select specimen sets of colon cancers and matching normal tissues and the results also indicated PDRG1 overexpression in tumors relative to normal tissues. To gain insight into the function of PDRG1, we performed PDRG1 knockdown in human colon cancer cells and found its depletion to result in marked slowdown of tumor cell growth. These results suggest that PDGR1 may be linked to cell growth regulation. Yeast two-hybrid screen also led to the identification of PDCD7, CIZ1 and MAP1S as PDRG1-interacting proteins that are involved in apoptosis and cell cycle regulation which further implicate PDRG1 in controlling cell growth regulation. Taken together, our results indicate that PDRG1 expression is increased in multiple human malignancies suggesting it to be a high-value novel tumor marker that could play a role in cancer development and/or progression.
机译:我们之前已经克隆并鉴定了一种新型的p53和DNA损伤调控基因PDRG1。发现PDRG1受紫外线(p53)的差异调节。在这项研究中,我们进一步研究了PDRG1的应激调节,并发现它被诱导遗传毒性应激(DNA损伤)的药物选择性调节。使用癌症概况分析阵列,我们还研究了在代表各种恶性肿瘤的正常和肿瘤样本中PDRG1的表达,并发现其表达在多种恶性肿瘤(包括结肠癌,直肠癌,卵巢癌,肺癌,胃癌,乳腺癌和子宫癌)中被上调。各自匹配的正常组织。还对选定的结肠癌和匹配的正常组织样本组进行了蛋白质印迹和免疫组织化学分析,结果还表明PDRG1在肿瘤中相对于正常组织过表达。为了深入了解PDRG1的功能,我们在人类结肠癌细胞中进行了PDRG1敲低,发现其耗尽导致肿瘤细胞生长明显减慢。这些结果表明PDGR1可能与细胞生长调节有关。酵母双杂交筛选还导致将PDCD7,CIZ1和MAP1S鉴定为与PDRG1相互作用的蛋白,这些蛋白与细胞凋亡和细胞周期调控有关,这进一步暗示了PDRG1参与细胞生长调控。综上,我们的结果表明PDRG1在多种人类恶性肿瘤中表达增加,表明它是一种高价值的新型肿瘤标志物,可能在癌症的发展和/或进程中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号